share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director Quincey James

SEC announcement ·  Apr 26 13:28
Summary by Moomoo AI
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
In a recent transaction, Quincey James, a reporting person for Pfizer Inc [PFE], executed a stock transaction on April 25, 2024. The details of the transaction, including the number of shares involved and the transaction price, have not been disclosed. The nature of the shares and the number of shares held by Quincey James after the action are also not provided. This information is essential for investors to understand the potential impact on their investment in Pfizer stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more